These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 14518408)
1. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer]. Nimura H; Mitsumori N; Tsukagoshi S; Nakajima M; Atomi Y; Suzuki S; Kusano M; Yoshiyuki T; Tokunaga A Gan To Kagaku Ryoho; 2003 Sep; 30(9):1289-96. PubMed ID: 14518408 [TBL] [Abstract][Full Text] [Related]
2. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer]. Nimura H; Mitsumori N; Takahashi N; Kashimura H; Takayama S; Kashiwagi H; Yanaga K Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():106-9. PubMed ID: 16897983 [TBL] [Abstract][Full Text] [Related]
3. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer]. Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928 [TBL] [Abstract][Full Text] [Related]
4. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report]. Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521 [TBL] [Abstract][Full Text] [Related]
5. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer]. Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529 [TBL] [Abstract][Full Text] [Related]
6. [A phase I study of combination chemotherapy using TS-1 and pirarubicin (THP) for advanced gastric cancer]. Yamamura Y; Kodera Y; Tanemura H; Oshita H; Miyashita K; Fujimura T; Gan To Kagaku Ryoho; 2004 Mar; 31(3):361-5. PubMed ID: 15045941 [TBL] [Abstract][Full Text] [Related]
7. [A pilot study of TS-1 combined with cisplatin in patients with advanced gastric cancer]. Iwase H; Shimada M; Nakamura M; Iyo T; Nakarai K; Kaida S; Indo T; Okeya M; Mizuno T; Ina K; Kusugami K Gan To Kagaku Ryoho; 2002 Sep; 29(9):1575-82. PubMed ID: 12355943 [TBL] [Abstract][Full Text] [Related]
8. [A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer]. Kamata T; Hayashi Y; Minatoya G; Michiwa Y; Onishi I; Takeda T; Koyasaki N; Kanno M Gan To Kagaku Ryoho; 2001 Oct; 28(10):1419-22. PubMed ID: 11681250 [TBL] [Abstract][Full Text] [Related]
9. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan]. Yagi M; Watanabe S; Yoshino S; Hazama S; Suga T; Nakazawa S Gan To Kagaku Ryoho; 2010 Mar; 37(3):457-62. PubMed ID: 20332683 [TBL] [Abstract][Full Text] [Related]
10. [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy]. Nakamura M; Maruyama K; Furukawa J; Maruyama N; Tanaka J; Katsumoto Y; Yokouchi H; Nakaguchi K; Sue F; Yoshihara W Gan To Kagaku Ryoho; 2002 Oct; 29(10):1823-8. PubMed ID: 12402437 [TBL] [Abstract][Full Text] [Related]
11. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer]. Nakata B; Hirakawa K Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921 [TBL] [Abstract][Full Text] [Related]
12. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer. Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer]. Yabusaki H; Nashimoto A; Tanaka O Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962 [TBL] [Abstract][Full Text] [Related]
14. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital]. Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711 [TBL] [Abstract][Full Text] [Related]
15. [Results of treatment of far advanced and recurrent stomach cancer with TS-1]. Johira H; Yunoki S; Kawata N; Watanabe N; Hachisuka Y; Kimura M; Uomoto M; Hatano H; Sanada E; Watanabe R; Ohmori K; Miyata N Gan To Kagaku Ryoho; 2005 Feb; 32(2):195-9. PubMed ID: 15751632 [TBL] [Abstract][Full Text] [Related]
16. A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer. Iwase H; Shimada M; Tsuzuki T; Horiuchi Y; Kumada S; Haruta J; Yamaguchi T; Sugihara M; Ina K; Kusugami K; Goto S Anticancer Res; 2005; 25(2B):1297-301. PubMed ID: 15865081 [TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer]. Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920 [TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study. Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092 [TBL] [Abstract][Full Text] [Related]
19. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer. Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558 [TBL] [Abstract][Full Text] [Related]
20. [A phase I study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer]. Fujiwara Y; Fujita J; Kan K; Tsukahara K; Takiguchi S; Miyata H; Yasuda T; Doki Y; Monden M Gan To Kagaku Ryoho; 2006 Jan; 33(1):45-8. PubMed ID: 16410697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]